Evidence map›Paper›PMID 38066667›Full record

ArticleTranslational behavioral medicine2023

Assessing the market viability of a packaged intensive health behavior and lifestyle treatment.

Alicia Persaud, Natalie Riva Smith, Jeanne Lindros, Jeremiah Salmon, Giustina Ventura, Meghan Perkins, Elsie M Taveras, Lauren Fiechtner, Meg Simione

Abstract read
In one paragraph

Article in Translational behavioral medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alicia PersaudDivision of General Academic Pediatrics, Mass General for Children, Boston, MA, USA.
Natalie Riva SmithDepartment of Social and Behavioral Sciences, Harvard TH Chan School of Public Health, Boston, MA, USA.ORCID 0000-0002-2052-9433
Jeanne LindrosInstitute for Healthy Childhood Weight, American Academy of Pediatrics, Itasca, IL, USA.
Jeremiah SalmonInstitute for Healthy Childhood Weight, American Academy of Pediatrics, Itasca, IL, USA.
Giustina VenturaDivision of General Academic Pediatrics, Mass General for Children, Boston, MA, USA.
Meghan PerkinsDivision of General Academic Pediatrics, Mass General for Children, Boston, MA, USA.
Elsie M TaverasDivision of General Academic Pediatrics, Mass General for Children, Boston, MA, USA.
Lauren FiechtnerDivision of General Academic Pediatrics, Mass General for Children, Boston, MA, USA.
Meg SimioneDivision of General Academic Pediatrics, Mass General for Children, Boston, MA, USA.ORCID 0000-0003-2636-9714

Funding

GWB MENTAL HEALTH SERVICE RESEARCH TRAININGT32MH019960 · NIMH · WASHINGTON UNIVERSITY · PI Leopoldo J Cabassa, Byron James Powell · 1995 to 2026
$11.1M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Adapting a pediatric weight management program for implementation via telehealthK23HL161447 · NHLBI · UNIVERSITY OF RHODE ISLAND · PI Meg Simione · 2022 to 2026
$709k
Creating effective childhood obesity interventions through the study ofpositive outliersK23HD090222 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI FIECHTNER, LAUREN GEHLER · 2018 to 2021
$696k
Patient Oriented Research and Mentorship in Childhood Obesity DisparitiesK24HL159680 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TAVERAS BENAVIDEZ, ELSIE MIREYA · 2021 to 2025
$510k
CDC HHS U18DP006424NCCDPHP CDC HHS U18 DP006424NHLBI NIH HHS K23HD090222NHLBI NIH HHS K23 HL161447NHLBI NIH HHS K24 HL159680NICHD NIH HHS K23 HD090222NIDDK NIH HHS P30 DK111022NIMH NIH HHS T32 MH019960NIMH NIH HHS T32MH019960
6 · The paper itself

Abstract

In the USA, more than 14 million children are impacted by obesity. Despite intensive health behavior and lifestyle treatments being found effective, gaps exist in moving these interventions into widespread use. Focusing on market viability could improve the dissemination and sustainment of interventions. The purpose of this paper is to outline the process and results of our market viability assessment for the Healthy Weight Clinic (HWC), a Centers for Disease Control and Prevention-recognized Family Health Weight Program. We conducted a market viability assessment using the Speeding Research-test INTerventions (SPRINT) program to gain insights into the commercialization and marketplace for the HWC. Through the process of customer discovery, we interviewed 50 stakeholders to test our hypotheses pertaining to our business model. Key takeaways were the need for packaged interventions that offer support and training for providers, and interventions that are multidisciplinary and located within the medical home. We also learned that (i) the intervention goals must align with the healthcare organization's performance metrics; (ii) services need to be reimbursable; and (iii) the importance of understanding different customer segments (i.e. program users vs. organization decision-makers) and their unique needs. The market viability assessment is a critical step to transforming the HWC into a viable commercial product. The process we have outlined is replicable by others and by encouraging other teams to design for dissemination we can increase the number of evidence-based, packaged IHBLTs available to children with obesity.

Indexed as

childhood obesitydisseminationimplementation sciencemarket viabilitypediatric weight management intervention

Identifiers

PMID38066667
PMCPMC10724182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.